pulmonary sarcoidosis
Conditions
Interventions
Sponsors
Sint Antonius Ziekenhuis
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: * Patients with diagnosis of sarcoidosis based on ATS/WASOG criteria 22 * Age * 18 years. * Life expectancy of at least 2 years. * Pulmonary function tests (spirometry) within one month of entry or willing to under pulmonary function testing on the day of study enrollment * Sarcoidosis as characterized as either advanced or non-advanced (see protocol for definition of advanced disease) * Subjects must be able to understand and be willing to sign the written informed consent form. A signed informed consent form must be appropriately obtained prior to the conduct of any trial-specific procedure.
Exclusion criteria
Exclusion criteria: * Subjects with a medical disorder, condition, or history of such that would impair the subject*s ability to participate or complete this study in the opinion of the investigator * Inability to comply with the protocol and/or not willing or not available for follow-up assessments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease development of advanced and non-advanced sarcoidosis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life for patients with advanced and non-advanced sarcoidosis as assessed using questionairs | — |
Countries
United States of America
Outcome results
None listed